Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo
about
Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epitheliumIncreased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokersMolecular biology of lung cancer: clinical implicationsIncreased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsiesChemoprevention of lung cancer: prospects and disappointments in human clinical trialsNicotine-mediated cell proliferation and tumor progression in smoking-related cancersLung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromiumClinical significance of phosphatidyl inositol synthase overexpression in oral cancer.Lung carcinoma signaling pathways activated by smoking.The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis.High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)A network-based biomarker approach for molecular investigation and diagnosis of lung cancer.Optimizing mouse models for precision cancer prevention.Akt1 deletion prevents lung tumorigenesis by mutant K-ras.Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention.Current concepts on the molecular pathology of non-small cell lung carcinoma.ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumorsNicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivinEfficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J miceATF3 Mediates Anti-Cancer Activity of Trans-10, cis-12-Conjugated Linoleic Acid in Human Colon Cancer Cells.Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinomaThe development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt.Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Targeted therapies for lung cancer: clinical experience and novel agentsEpithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"?Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitorsPersonalizing lung cancer prevention through a reverse migration strategy.Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesThe ERBB3 receptor in cancer and cancer gene therapyMolecular changes in smoking-related lung cancer.Environmental factors in causing human cancers: emphasis on tumorigenesis.Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling.AKT in cancer: new molecular insights and advances in drug development.Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia.
P2860
Q24306139-E9FD9C1C-F50E-4130-A5A8-4B182C3075D6Q24595630-70EB0BCF-F972-4321-BE45-05409C7A94C1Q24610335-339AD66F-E466-49FA-AE11-92982204DCD8Q25257717-E0246F1F-B6EB-4C35-92A4-2725AF3BEF68Q28386632-31012DB4-0555-49E1-B10C-70A9D5241B9CQ28395572-D7EAB312-A234-4DCC-9B65-8E118D92D069Q28397511-0FBF0B7C-F7A1-4C96-A236-23F7FF33A973Q33567362-F115A17F-CA4C-466A-93C2-8A86A7E2DEA1Q33579679-EBA09DE7-8C8E-40C0-A696-405C68D2792BQ33584802-833EEBAA-0061-4AB2-9B43-A461E4DBB4ACQ33717222-E03465C2-3BA7-447F-93BB-FF1FB6C77C89Q33787452-EFFD744B-61B7-4AAC-9EAA-63E049608674Q33919192-16176E06-D101-4216-8439-DE4DB5235021Q34049042-F11A06FA-1137-48EE-8ABD-7A3E32A1F831Q34130786-A09331F2-4234-4C59-B080-ED0869E27546Q34310062-98E1E8E1-C8D6-4430-897E-2CB4F75A485FQ34577233-98BF3D80-ABF5-47E7-B9D8-9D693BF120F4Q34597500-636BEE1A-BFCB-47F5-A7ED-B4A634980ABDQ35060293-26E15F6F-DCD3-4E53-B999-798C497EA61AQ35161272-CA5CE3A6-A904-4D72-B677-1A19EFD19682Q35741627-6E120E1C-9D98-4730-9D29-F6FD58CEEAF7Q35814450-E8FE8175-A0E9-4343-8DF9-B1CFBA161D35Q35994228-76599BE6-47A6-4BC7-9974-8559217AEBDCQ36054970-09078749-26F1-4A28-A66E-DC2B05346CD2Q36399326-EC727F42-16D2-4087-AC6D-1AF59C010F07Q36528118-897094F2-5996-48AE-9F19-4E99F3B20048Q36890658-C026206D-0543-45E7-9F60-39E96CF8E1A0Q36907221-E4794621-9758-4167-8166-05233B95BCCDQ37080513-9C2F807A-C5A0-4CFB-B482-B02F3A742AC1Q37111529-B760CA94-8C13-441D-AE22-F110EF0E7343Q37135372-AE5971E2-341E-482B-A96B-93F563554624Q37963519-B1C7E5A4-2065-49F1-AA4D-FB12A5CA83A8Q38012014-EC103606-F4E5-42AB-81DA-3A68D0BEDD35Q38100162-F84F78C5-DC9C-4D77-86CF-7EDA3BA776ACQ38514782-532BA9B0-7313-443E-AD11-1103990AD48AQ38687241-738D573D-3DD6-4F6B-9240-D13DF247E0A2Q38846044-4D0A6AF8-2643-4E95-883E-125C6344864DQ38857550-E755FAC4-3C90-41E7-9D9F-95115890EF09Q39004659-8230E407-34F3-4199-BD86-E7307F74793CQ39493744-BCFE5595-2A31-4D64-9616-87635C08F645
P2860
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@ast
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@en
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@nl
type
label
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@ast
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@en
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@nl
prefLabel
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@ast
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@en
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@nl
P2093
P1433
P1476
Tobacco carcinogen-induced cel ...... t pathway in vitro and in vivo
@en
P2093
Curtis C Harris
Ilona R Linnoila
Kip A West
Phillip A Dennis
Steven A Belinsky
P304
P356
10.1158/0008-5472.CAN-03-3241
P407
P577
2004-01-15T00:00:00Z